A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Explore the Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Adult Male Subjects

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Explore the Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2014

At a glance

  • Drugs Oliceridine (Primary) ; Morphine
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Trevena
  • Most Recent Events

    • 03 May 2014 Primary endpoint 'Pain-relief' has been met.
    • 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
    • 14 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top